Lexicon Pharmaceuticals, Inc. - LXRX Choraklik daromad o'sishi

lexpharma.com (LXRX) - korporativ logo

Lexicon Pharmaceuticals ishlab chiqarish quvvatlari metabolik agentlarni ishlab chiqarish uchun to'liq optimallashtirilgan. Daromadlar sug'urta fondlari va davlat dasturlari orqali patentlangan dori vositalarining sotuviga asoslangan. -20.80 metrik qiymatiga ega bo'lgan choraklik sotuvlar o'sishi Inpefa ning tijoratlashtirish salohiyatini tasdiqlaydi, bu esa sug'urta qamrovining kengayishi va FDA qarorini aktiv qiymati o'sishi uchun asosiy katalizatorlarga aylantiradi.

LXRX Lexicon Pharma Choraklik sotuv ortish sur'ati (04.07.2022 - 20.11.2026)

Lexicon Pharmaceuticals, Inc. - tahliliy kesimlar va asosiy koʻrsatkichlar (LXRX)

- joriy kotirovkalar va o'rtacha qiymat prognozi:
- pul mablag'lari va pul oqimlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Lexicon Pharmaceuticals, Inc. - LXRX
lexpharma.com seriyali mahsuloti

Lexicon Pharmaceuticals (LXRX) daromadlari yurak va endokrin patologiyalarini davolovchi yuqori narxli dori vositalari uchun sug'urta to'lovlariga bog'liq. Choraklik daromadlar o'sish sur'atini tahlil qilish orqali investor kompaniyaning bozor kengayishining real dinamikasini baholaydi. Ushbu ko'rsatkich choraklar orasidagi pul oqimlarining kirish tezligini o'lchaydi, bu esa bozor shovqinlarini filtrlash va operatsion siklning haqiqiy bosqichini aniqlash imkonini beradi. Bunday ko'rsatkichlar biotexnologik aktivlarning fundamental qiymatini baholash uchun juda muhimdir.

Toʻgʻridan-toʻgʻri raqobatchilar

ASND - Daromadning choraklik o'sishi (QoQ)|MDGL: Daromadning choraklik o'sishi (QoQ)|CORT: Choraklik daromad o'sishi|RYTM - Choraklik sotuv ortish sur'ati|Daromadning choraklik o'sishi (QoQ) Akero Corp|Metsera Therapeutics (MTSR) - Choraklik sotuv ortish sur'ati|Daromadning choraklik o'sishi (QoQ) moonlaketx.com (MLTX)|Choraklik sotuv o'sishi Crinetics Pharmaceuticals CRNX|Daromadning choraklik o'sishi (QoQ) NewAmsterdam Pharma N.V. NAMS|Choraklik sotuv ortish sur'ati Soleno Therapeutics Inc (SLNO)|FOLD - Daromadning choraklik o'sishi (QoQ)|ETNB: Daromadning choraklik o'sishi (QoQ)|AGIO: Choraklik daromad o'sishi|Structure Therapeutics Inc. - Choraklik daromad ortishi|MDXG (MiMedx Corp) - Choraklik daromad o'sishi|Choraklik daromad o'sish sur'ati Rezolute Inc RZLT|Choraklik daromad o'sishi MBX|Choraklik sotuv o'sishi Altimmune, Inc. ALT|Choraklik daromad o'sishi AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Choraklik daromad o'sish sur'ati|BIOA: Choraklik sotuv o'sishi|Choraklik daromad ortishi BMEA (Biomea Fusion)|QNCX (quincetx.com) - Choraklik sotuv o'sishi|Fractyl - Choraklik daromad ortishi|VTVT (vTv Therapeutics Inc) - Choraklik daromad o'sishi|Agape ATP - Daromadning choraklik dinamikasi|Choraklik sotuv o'sishi PLUR (Pluri Inc)|Choraklik sotuv ortish sur'ati Synlogic Inc.|Daromadning choraklik o'sishi (QoQ) Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Choraklik daromad o'sish sur'ati|Spruce Biosciences Inc. - Choraklik daromad o'sishi|Choraklik sotuv ortish sur'ati Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Daromadning choraklik o'sishi (QoQ)|Lumos Pharma - Choraklik daromad ortishi|ONVO (Organovo Corp) - Choraklik daromad o'sishi|Radius Pharmaceuticals (RDUS) - Choraklik sotuv ortish sur'ati